The reversal of no reflow and its effect on clinical outcome

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 3, 2008, Pages 290-

  Satler, Lowell F ^a,b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ACUTE HEART INFARCTION; CLINICAL TRIAL; DRUG MEGADOSE; HUMAN; MEDICAL ASSISTANT; NOTE; PERCUTANEOUS CORONARY INTERVENTION; THROMBECTOMY; TREATMENT OUTCOME;

ADENOSINE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRALESIONAL; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41149087850     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21495     Document Type: Note

References (1)

1. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann FJ, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: A meta-analysis of randomized trials. Am Heart J 2007;153:343-353.